House committee substitute to the 3rd edition makes the following changes.

Amends GS 115C-375.2A(b) (in Section 4.(b)) and GS 90-21.15A(a)(3) (in Section 4.1) by changing the types of nasal sprays and injectors specifically included in the definition of “epinephrine delivery system” to those approved by the U.S. Food and Drug Administration (FDA) with a premeasured, appropriate weight-based dose of epinephrine (was, nasal sprays and injectors with a spring-activated, concealed needle).

Eliminates Part VI, Adult Care Home Medicaid Personal Care Services, which required the Department of Health and Human Services, Division of Health Benefits to explore options available to increase access to Medicaid services for dual eligibles that provide alternatives to nursing home placement, submit a request to the Centers for Medicare and Medicaid Services meeting listed goals, and take any other necessary actions to implement the act.

Former Part VII. Effective Date is now Part VI.